AMAG PHARMACEUTICALS INC (AMAG)

Overview Price 16.22 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $16.22 Daily Range $0.00 - $0.00 52-Week Range $12.65 - $19.62 Volume 0 AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Ferumoxytol, the company's key product candidate, is being developed for use as an intravenous iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease patients.Combidex?, the company's other product under development, is an investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging to aid in the differentiation of cancerous from normal lymph nodes. In March 2005, the company received an approvable letter from the FDA with respect to Combidex, subject to certain conditions. Other Resources for AMAG Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Allos Therapeutics Cut to Neutral January 12, 2012 Zacks Blog: AMAG Q4 Sales Set to Disappoint January 11, 2012 Zacks Blog: AMAG's Feraheme Gets Canada Nod December 15, 2011 Zacks Blog: Allos Continues to Outperform November 25, 2011 Zacks Blog: AMAG Hires Financial Advisor November 18, 2011 AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Ferumoxytol, the company's key product candidate, is being developed for use as an intravenous iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease patients.Combidex?, the company's other product under development, is an investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging to aid in the differentiation of cancerous from normal lymph nodes. In March 2005, the company received an approvable letter from the FDA with respect to Combidex, subject to certain conditions.   Brokerage Analyst Recommendations 7 Brokerage Firms Covering AMAG   Strong Buy 3 Buy 0 Hold 2 Sell 1 Strong Sell 1 Average Broker Recommendation (ABR): 2.57   AMAG Ratings: BUY  SELL  HOLD AMAG Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 11 Buy 1 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
rjm77me	99.92	11/05/10	Insider Trading Summary: Notable Purchases / sales	0
zantriocom	0.00	02/08/10	Zantrio.com Free Daily Stock Picks 2-8-2010	0
Zacks_Analysts	0.00	01/12/12	Allos Therapeutics Cut to Neutral - Analyst Blog	0
Zacks_Analysts	0.00	01/11/12	AMAG Q4 Sales Set to Disappoint - Analyst Blog	0
Zacks_Analysts	0.00	12/15/11	AMAG's Feraheme Gets Canada Nod - Analyst Blog	0
Zacks_Analysts	0.00	11/25/11	Allos Continues to Outperform - Analyst Blog	0
Zacks_Analysts	0.00	11/18/11	AMAG Hires Financial Advisor - Analyst Blog	0
Zacks_Analysts	0.00	11/08/11	Allos Narrows Loss - Analyst Blog	0
Zacks_Analysts	0.00	11/08/11	Loss Shrinks at AMAG, CEO Departs - Analyst Blog	0
Zacks_Analysts	0.00	10/24/11	AMAG/Allos Deal Called Off - Analyst Blog	0

Pages: [ 1 ]  2   3   4  >>

Commentary

BUY: AMAG PHARMACEUTICALS INC. (AMAG) Start Price: $52.81 Points: -119.92 Created: 07/02/2009 Comments: 0 | Comment jnill Recs:

BUY: AMAG PHARMACEUTICALS INC. (AMAG) Start Price: $32.24 Points: -86.61 Created: 10/20/2008 Comments: 0 | Comment Revolver Recs:

BUY: AMAG PHARMACEUTICALS INC. (AMAG) Start Price: $19.10 Points: -6.74 Created: 01/01/2008 Comments: 0 | Comment Sunshiner Recs:

SELL: AMAG PHARMACEUTICALS INC. (AMAG) Start Price: $64.41 Points: +66.77 Created: 01/01/2008 Comments: 0 | Comment Lorr12 Recs:

BUY: AMAG PHARMACEUTICALS INC. (AMAG) Start Price: $40.13 Points: -51.46 Created: 01/01/2008 Comments: 0 | Comment DonnaBee Recs:

BUY: AMAG PHARMACEUTICALS INC. (AMAG) Start Price: $26.25 Points: -29.98 Created: 01/01/2008 Comments: 0 | Comment WizardZero Recs:

BUY: AMAG PHARMACEUTICALS INC. (AMAG) Start Price: $14.80 Points: +18.06 Created: 01/01/2008 Comments: 0 | Comment joesef Recs:

BUY: AMAG PHARMACEUTICALS INC. (AMAG) Start Price: $38.25 Points: -49.46 Created: 01/01/2008 Comments: 0 | Comment YngInvestor Recs:

BUY: AMAG PHARMACEUTICALS INC. (AMAG) Start Price: $38.19 Points: -49.40 Created: 01/01/2008 Comments: 0 | Comment CapJack Recs:

BUY: AMAG PHARMACEUTICALS INC. (AMAG) Start Price: $63.84 Points: -66.55 Created: 01/01/2008 Comments: 0 | Comment arusha Recs:

Pages: [ 1 ]  2  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
jnill	2.60	BUY	One to Three Months	07/02/2009	$52.81	$16.30 (-1.57%)	-69.13%	+50.79%	-119.92
Revolver	73.61	BUY	Six Months to a Year	10/20/2008	$32.24	$16.30 (-1.57%)	-49.44%	+37.17%	-86.61
Sunshiner	10.67	BUY	Six Months to a Year	01/01/2008	$19.10	$16.30 (-1.57%)	-14.66%	-7.92%	-6.74
Lorr12	72.43	SELL	Six Months to a Year	01/01/2008	$64.41	$16.30 (-1.57%)	-74.69%	-7.92%	+66.77
DonnaBee	13.16	BUY	Six Months to a Year	01/01/2008	$40.13	$16.30 (-1.57%)	-59.38%	-7.92%	-51.46
WizardZero	23.00	BUY	Six Months to a Year	01/01/2008	$26.25	$16.30 (-1.57%)	-37.90%	-7.92%	-29.98
joesef	72.43	BUY	Six Months to a Year	01/01/2008	$14.80	$16.30 (-1.57%)	+10.14%	-7.92%	+18.06
YngInvestor		BUY	Six Months to a Year	01/01/2008	$38.25	$16.30 (-1.57%)	-57.39%	-7.92%	-49.46
CapJack	21.03	BUY	Six Months to a Year	01/01/2008	$38.19	$16.30 (-1.57%)	-57.32%	-7.92%	-49.40
arusha	60.96	BUY	Six Months to a Year	01/01/2008	$63.84	$16.30 (-1.57%)	-74.47%	-7.92%	-66.55

Pages: [ 1 ]  2  >>